Prognostic factors in idiopathic membranous nephropathy

American Journal of Kidney Diseases

Volumn 31, Issue 1, 1998, Pages 1-11

  Reichert, Louis J M ^a,b   Koene, Robert A P ^a   Wetzels, Jack F M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Sittard Geleen Heerlen   (Netherlands)

Author keywords

Kidney failure; Membranous nephropathy; Prognostic factors

Indexed keywords

ALBUMIN; ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; BETA 2 MICROGLOBULIN; CARRIER PROTEIN; CHOLESTEROL; COMPLEMENT; COMPLEMENT COMPONENT C3D; COMPLEMENT MEMBRANE ATTACK COMPLEX; CREATININE; CYCLOPHOSPHAMIDE; HLA ANTIGEN; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENT; PREDNISONE; PROTEIN;

AGE; CLINICAL TRIAL; ELECTRON MICROSCOPY; GENE; HEREDITY; HUMAN; HYPERTENSION; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY FUNCTION; MEMBRANOUS GLOMERULONEPHRITIS; MICROSCOPY; NONHUMAN; PROGNOSIS; PROTEINURIA; RACE; REVIEW; RISK FACTOR; SCLEROSIS; SEX;

EID: 0031883811     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.1998.v31.pm9428445     Document Type: Article

References (74)

1. Couser WG, Salant DJ, Adler S, Madaio MP: Studies of experimental membranous nephropathy. Transplant Proc 14:474-481, 1982
2. Brenchley PEC, Short CD, Feehally J, Mallick NP: Towards defining antigens in human membranous nephropathy. Nephrol Dial Transplant 7:21-24, 1992 (suppl 1)
3. Idiopathic membranous nephropathy. Report of a meeting of physicians and scientists. Clinical Research Centre for Rare Diseases, Mario Negri Institute, Bergamo. Lancet 342:1277-1280,1993
4. Lai KN, Li PK, Lui SF, Au TC, Tam JS, Tong KL, Lai FM: Membranous nephropathy related to hepatitis B virus in adults. N Engl J Med 324:1457-1463, 1991
5. Ponticelli C, Zuccelli P, Passerini P, Cesana B, Locatelli F, Pasquali S, Sasdelli M, Redaelli B, Grassi C, Pozzi C, Bizzarri D, Banfi G: A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy. Kidney Int 48:1600-1604, 1995
6. Cattran DC: Cytotoxics, cyclosporine and membranous nephropathy. Curr Opin Nephrol Hypertens 5:427-436, 1996
7. Ponticelli C, Zucchelli P, Imbasciati E, Cagnoli L, Pozzi C, Passerini P, Grassi C, Limido D, Pasquali S, Volpini T, Sasdelli M, Locatelli F: Controlled trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy. N Engl J Med 310:946-950,1984
8. Piccoli A, Pillon L, Passerini P, Ponticelli C: Therapy for idiopathic membranous nephropathy: Tailoring the choice by decision analysis. Kidney Int 45:1193-1202, 1994
9. Cameron JS, Healy MJ, Adu D: The Medical Research Council trial of short-term high-dose alternate day prednisolone in idiopathic membranous nephropathy with nephrotic syndrome in adults. The MRC Glomerulonephritis Working Party. QJ Med 74:133-156, 1990
10. Cameron JS: Pathogenesis and treatment of membranous nephropathy. Kidney Int 15:88-103,1979
11. Davison AM, Cameron JS, Kerr DN, Ogg CS, Wilkinson RW: The natural history of renal function in untreated idiopathic membranous glomerulonephritis in adults. Clin Nephrol 22:61-67, 1984
12. A controlled study of short-term prednisone treatment in adults with membranous nephropathy. Collaborative Study of the Adult Idiopathic Nephrotic Syndrome. N Engl J Med 301:1301-1306,1979
13. Donadio JVJ, Torres VE, Velosa JA, Wagoner RD, Holley KE, Okamura M, Ilstrup DM, Chu CP: Idiopathic membranous nephropathy: The natural history of untreated patients. Kidney Int 33:708-715, 1988
14. Murphy BF, Fairley KF, Kincaid-Smith PS: Idiopathic membranous glomerulonephritis: Long-term follow-up in 139 cases. Clin Nephrol 30:175-181, 1988
15. Tu WH, Petitti DB, Biava CG, Tulunay O, Hopper JJ: Membranous nephropathy: Predictors of terminal renal failure. Nephron 36:118-124, 1984
16. Fuiano G, Stanziale P, Balletta M, Sepe V, Marinelli G, Comi N, Esposito A, Andreucci VE: Effectiveness of steroid therapy in different stages of membranous nephropathy. Nephrol Dial Transplant 4:1022-1029, 1989
17. Schieppati A, Mosconi L, Perna A, Mecca G, Bertani T, Garattini S, Remuzzi G: Prognosis of untreated patients with idiopathic membranous nephropathy. N Engl J Med 329:85-89,1993
18. Mallick NP, Short CD, Manos J: Clinical membranous nephropathy. Nephron 34:209-219, 1983
19. Abe S, Amagasaki Y, Konishi K, Kato E, Iyori S, Sakaguchi H: Idiopathic membranous glomerulonephritis: Aspects of geographical differences. J Clin Pathol 39:1193-1198, 1986
20. Honkanen E: Survival in idiopathic membranous glomerulonephritis. Clin Nephrol 25:122-128, 1986
21. Klouda PT, Manos J, Acheson EJ, Dyer PA, Goldby FS, Harris R, Lawler W, Mallick NP, Williams G: Strong association between idiopathic membranous nephropathy and HLA-DRW3. Lancet 2:770-771, 1979
22. Muller GA, Muller C, Liebau G, Kompf J, Ising H, Wernet P: Strong association of idiopathic membranous nephropathy (IMN) with HLA-DR3 and MT-2 without involvement of HLA-B 18 and no association to BfFl. Tissue Antigens 17:332-337, 1981
23. Freedman BI, Spray BJ, Dunston GM, Heise ER: HLA associations in end-stage renal disease due to membranous glomerulonephritis: HLA-DR3 associations with progressive renal injury. Southeastern Organ Procurement Foundation. Am J Kidney Dis 23:797-802,1994
24. Ogahara S, Naito S, Abe K, Michinaga I, Arakawa K: Analysis of HLA class II genes in Japanese patients with idiopathic membranous glomerulonephritis. Kidney Int 41: 175-182, 1992
25. Chevrier D, Giral M, Braud V, Soulillou JP, Bignon JD: Membranous nephropathy and a TAP1 gene polymorphism. N Engl J Med 331:133-134, 1994 (letter)
26. Zucchelli P, Ponticelli C, Cagnoli L, Aroldi A, Tabacchi P: Genetic factors in the outcome of idiopathic membranous nephropathy. Nephrol Dial Transplant 1:265-266, 1987 (letter)
27. Short CD, Dyer PA, Caims SA, Manos J, Walton C, Harris R, Mallick NP: A major histocompatibility system haplotype associated with poor prognosis in idiopathic membranous nephropathy. Disease Markers 1:189-196,1983
28. Hiki Y, Kobayashi Y, Itoh I, Kashiwagi N: Strong association of HLA-DR2 and MT1 with idiopathic membranous nephropathy in Japan. Kidney Int 25:953-957, 1984
29. Tomura S, Kashiwabara H, Tuchida H, Shishido H, Sakurai S, Miyajima T, Tsuji K, Takeuchi J: Strong association of idiopathic membranous nephropathy with HLA-DR2 and MT1 in Japanese. Nephron 36:242-245, 1984
30. Kida H, Asamoto T, Yokoyama H, Tomosugi N, Hattori N: Long-term prognosis of membranous nephropathy. Clin Nephrol 25:64-69, 1986
31. Passerini P, Pasquali S, Cesana B, Zucchelli P, Ponticelli C: Long-term outcome of patients with membranous nephropathy after complete remission of proteinuria. Nephrol Dial Transplant 4:525-529, 1989
32. Ponticelli C, Passerini P, Altieri P, Locatelli F, Pappalettera M: Remissions and relapses in idiopathic membranous nephropathy. Nephrol Dial Transplant 7:85-90, 1992 (suppl 1)
33. Jindal K, West M, Bear R, Goldstein M: Long-term benefits of therapy with cyclophosphamide and prednisone in patients with membranous glomerulonephritis and impaired renal function. Am J Kidney Dis 19:61-67, 1992
34. Row PG, Cameron JS, Turner DR, Evans DJ, White RH, Ogg CS, Chantier C, Brown CB: Membranous nephropathy. Long-term follow-up and association with neoplasia. Q J Med 44:207-239, 1975
35. Wehrmann M, Bohle A, Bogenschutz O, Eissele R, Freislederer A, Ohlschlegel C, Schumm G, Batz C, Gartner HV: Long-term prognosis of chronic idiopathic membranous glomerulonephritis. An analysis of 334 cases with particular regard to tubulo-interstitial changes. Clin Nephrol 31:67-76, 1989
36. Noel LH, Zanetti M, Droz D, Barbanel C: Long term prognosis of idiopathic membranous glomerulonephritis. Study of 116 untreated patients. Am J Med 66:82-90, 1979
37. Ehrenreich T, Porush JG, Churg J, Garfinkel L, Glabman S, Goldstein MH, Grishman E, Yunis SL: Treatment of idiopathic membranous nephropathy. N Engl J Med 295:741-746, 1976
38. MacTier R, Boulton-Jones JM, Payton CD, McLay A: The natural history of membranous nephropathy in the West of Scotland. Q J Med 60:793-802, 1986
39. Ponticelli C, Zucchelli P, Passerini P, Cagnoli L, Cesana B, Pozzi C, Pasquali S, Imbasciati E, Grassi C, Redaelli B, Sasdelli M, Locatelli F: A randomized trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy. N Engl J Med 320:8-13, 1989
40. Zucchelli P, Ponticelli C, Cagnoli L, Passerini P: Long-term outcome of idiopathic membranous nephropathy with nephrotic syndrome. Nephrol Dial Transplant 2:73-78, 1987
41. Ehrenreich T, Churg J: Pathology of membranous nephropathy. Pathol Annu 3:145-186, 1968
42. Erwin DT, Donadio JVJ, Holley KE: The clinical course of idiopathic membranous nephropathy. Mayo Clin Proc 48:697-712, 1973
43. Beregi E, Varga I: Analysis of 260 cases of membranous glomerulonephritis in renal biopsy material. Clin Nephrol 6:215-221, 1974
44. Ramzy MH, Cameron JS, Turner DR, Neild GH, Ogg CS, Hicks J: The long-term outcome of idiopathic membranous nephropathy. Clin Nephrol 16:13-19, 1981
45. Shearman JD, Tin ZG, Aarons I, Smith PS, Woodroffe AJ, Clarkson AR: The effect of treatment with prednisolone or cyclophosphamide-warfarin-dipyridamole combination on the outcome of patients with membranous nephropathy. Clin Nephrol 30:320-329, 1988
46. Ponticelli C, Zucchelli P, Passerini P, Cesana B: Methylprednisolone plus chlorambucil as compared with methylprednisolone alone for the treatment of idiopathic membranous nephropathy. The Italian Idiopathic Membranous Nephropathy Treatment Study Group. N Engl J Med 327:599-603, 1992
47. Forland M, Spargo BH: Clinicopathological correlations in idiopathic nephrotic syndrome with membranous nephropathy. Nephron 6:498-525, 1969
48. Wakai S, Magil AB: Focal glomerulosclerosis in idiopathic membranous glomerulonephritis. Kidney Int 41:428-434, 1992
49. Lee HS, Koh HI: Nature of progressive glomerulosclerosis in human membranous nephropathy. Clin Nephrol 39:7-16, 1993
50. Davenport A, Maciver AG, Hall CL, MacKenzie JC: Do mesangial immune complex deposits affect the renal prognosis in membranous glomerulonephritis? Clin Nephrol 41:271-276, 1994
51. Magil AB: Tubulointerstitial lesions in human membranous glomerulonephritis: Relationship to proteinuria. Am J Kidney Dis 25:375-379, 1995
52. Toth T, Takebayashi S: Factors contributing to the outcome in 100 adult patients with idiopathic membranous glomerulonephritis. Int Urol Nephrol 26:93-106, 1994
53. Abe S, Amagasaki Y, Iyori S, Konishi K, Kato E, Sakaguchi H: Significance of tubulointerstitial lesions in biopsy specimens of glomerulonephritic patients. Am J Nephrol 9:30-37, 1989
54. Kibriya MG, Tishkov I, Nikolov D: Immunosuppressive therapy with cyclophosphamide and prednisolone in severe idiopathic membranous nephropathy. Nephrol Dial Transplant 9:138-143, 1994
55. Wang H, Tomino Y, Fukui M, Shirato I, Yaguchi Y, Ebihara I, Kubota M, Nakayama S, Koide H: Correlation between tubulointerstitial changes and prognosis in patients with primary membranous nephropathy. Nephron 67:362, 1994 (letter)
56. Honkanen E, Tornroth T, Gronhagen-Riska C, Sankila R: Long-term survival in idiopathic membranous glomerulonephritis: Can the course be clinically predicted? Clin Nephrol 41:127-134, 1994
57. Cattran DC, Pei Y, Greenwood C: Predicting progression in membranous glomerulonephritis. Nephrol Dial Transplant 7:48-52, 1992 (suppl 1)
58. Pei Y, Cattran D, Greenwood C: Predicting chronic renal insufficiency in idiopathic membranous glomerulonephritis. Kidney Int 42:960-966, 1992
59. Cattran DC, Pei Y, Greenwood CMT, Ponticelli C, Passerini P, Honkanen E: Validation of a predictive model of idiopathic membranous nephropathy: Its clinical and research implications. Kidney Int 51:901-907, 1997
60. Pierides AM, Malasit P, Morley AR, Willkinson R, Uldall PR, Kerr DN: Idiopathic membranous nephropathy. QJ Med 46:163-177, 1977
61. Hunt LP: Statistical aspects of survival in membranous nephropathy. Nephrol Dial Transplant 7:53-59, 1992 (suppl 1)
62. Reichert UM, Koene RAP, Wetzels JFM: Urinary IgG excretion as a prognostic factor in idiopathic membranous nephropathy. Clin Nephrol 48:79-84, 1997
63. Reichert LJM, Koene RAP, Wetzels JFM: Urinary excretion of β2-microglobulin predicts renal outcome in patients with idiopathic membranous nephropathy. J Am Soc Nephrol 6:1666-1669, 1995
64. Coupes BM, Short CD, Brenchley PEC, Boyd S, Mallick NP: Urinary complement breakdown product C3dg in membranous nephropathy: A marker of disease activity? Proc Eur Dial Transplant Assoc 22:790-795, 1985
65. Brenchley PEC, Coupes B, Short CD, O'Donoghue DJ, Ballardie FW, Mallick NP: Urinary C3dg and C5b-9 indicate active immune disease in human membranous nephropathy. Kidney Int 41:933-937, 1992
66. Coupes B, Brenchley PEC, Short CD, Mallick NP: Clinical aspects of C3dg and C5b-9 in human membranous nephropathy. Nephrol Dial Transplant 7:32-34, 1992 (suppl 1)
67. Coupes BM, Kon SP, Brenchley PEC, Short CD, Mallick NP: The temporal relationship between urinary C5b-9 and C3dg and clinical parameters in human membranous nephropathy. Nephrol Dial Transplant 8:397-401, 1993
68. Kon SP, Coupes B, Short CD, Solomon LR, Raftery MJ, Mallick NP, Brenchley PE: Urinary C5b-9 excretion and clinical course in idiopathic human membranous nephropathy. Kidney Int 48:1953-1958, 1995
69. Ogrodowski JL, Hebert LA, Sedmak D, Cosio FG, Tamerius J, Kolb W: Measurement of C5b-9 in urine in patients with the nephrotic syndrome. Kidney Int 40:1141-1147, 1991
70. Marx BE, Marx M: Prognosis of idiopathic membranous nephropathy: A methodologic meta-analysis. Kidney Int 51:873-879, 1997
71. Reichert LJM, Huysmans FTM, Assmann K, Koene RAP, Wetzels JFM: Preserving renal function in patients with membranous nephropathy: Daily oral chlorambucil compared with intermittent monthly pulses of cyclophosphamide. Ann Intern Med 121:328-333, 1994
72. Glassock RJ, Cohen AH, Adler SG: Primary glomerular diseases, in Brenner BM (ed): The Kidney (ed 5). Philadelphia, PA, Saunders, 1996, pp 1392-1497
73. Habib R, Kleinknecht C, Gubler MC: Extramembranous glomerulonephritis in children: Report of 50 cases. J Pediatr 82:754-766, 1973
74. Passerini P, Como G, Vigano E, Melis P, Pozzi C, Altieri P, Ponticelli C: Idiopathic membranous nephropathy in the elderly. Nephrol Dial Transplant 8:1321-1325, 1993